Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial

Title
Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial
Authors
Keywords
-
Journal
HAEMATOLOGICA
Volume 101, Issue 7, Pages 821-829
Publisher
Ferrata Storti Foundation (Haematologica)
Online
2016-04-22
DOI
10.3324/haematol.2016.143644

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started